Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Evolving High Content Screening With the IX83 Inverted Microscope Frame

Published: Thursday, July 25, 2013
Last Updated: Thursday, July 25, 2013
Bookmark and Share
Olympus has expanded the scope of its most advanced IX83 inverted microscope frame, incorporating the scan^R 2.4 high content screening station for greater flexibility and increased scan speeds in a range of cell-based assays.

The scan^R 2.4 high content screening station is the latest addition to the growing collection of microscopy systems based upon the new IX3 high-end inverted microscope frame.

Thanks to its unique “open source” design concept, the IX3 is offering a completely modular and flexible approach to live cell imaging.

Built around a swappable deck design, optical modules can be easily exchanged into the accessible infinite light path, moulding the IX3 microscope to the diverse requirements of the user.

The updated Olympus scan^R 2.4 high content screening station can now be incorporated with the most advanced model of the IX3 range, the fully automated IX83, combining benefits of a modular frame design with increased scan speed.

This new system delivers quantitative expert results in a vast array of high content screening of cell-based assays, from gene expression to bacterial infection assays.

Keeping pace with the IX3 platform, the scan^R 2.4 software capabilities have also been extended, including fully supported multi-core analysis and unique kinetic analysis for advanced microscopy techniques.

Furthermore, cell population data can be easily exported so users can jointly benefit from all the flexibility offered by complex experiments in the Olympus xcellence imaging software.

The workflow-orientated graphical user interface has also been updated, allowing the advanced capabilities of the scan^R 2.4 station to be operated in a straightforward and intuitive manner, for routine and highly complex assays alike.

These new features build upon the performance of the scan^R stations’ high speed image acquisition and analysis. The dedicated real-time controller ensures precise timing of image capture, avoiding photobleaching and phototoxicity while maintaining the optimum scan speed.

Designed to be flexible to user requirements, the scan^R 2.4 station is optimized for many different assay formats, including multi-well plates, slides and custom-built arrays.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!